Senior insider sale
General Counsel at NURIX THERAPEUTICS, INC. — senior position signals high conviction
$558.8K
34.32K shares
What this filing means
RING CHRISTINE plans to sell 34.32K shares of NURIX THERAPEUTICS, INC. valued at approximately $558.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/2/2026ACC: 0001950047-26-003216
Officer· General Counsel
Since Jul 2020
34.32K
Shares to sell
$558.8K
Approx. market value
8.15K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
5/2/2022
8.15KTotal acquired8.15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/2/2022 | Restricted Stock Units N/A | 8.15K | — |
| Total | 8.15K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
8.15K
Market value
$125.8K
3/2/2026
—Completed
Units to sell
6.11K
Market value
$101.9K
2/9/2026
—Completed
Units to sell
8.15K
Market value
$135.8K
2/9/2026
—Completed
Units to sell
3.76K
Market value
$69.3K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
8.15K
Market value
$126.1K
4/2/2026
Total
Units
34.32K
Value
$558.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/2/2026 | 8.15K | $125.8K | — | Completed |
2/9/2026 | 6.11K | $101.9K | — | Completed |
2/9/2026 | 8.15K | $135.8K | — | Completed |
1/20/2026 | 3.76K | $69.3K | — | Completed |
| Planned — Approximate Date | ||||
4/2/2026 | 8.15K | $126.1K | NASDAQ | Planned |
| Total | 34.32K | $558.8K | ||